ACADIA Pharmaceuticals Inc. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

1. Notable

   Carbetocin Nasal Spray · Hyperphagia in Prader-Willi Syndrome

   Primary endpoint(s) modified

   Also in this update: Results posted: Oct 15, 2026; Trial completed

   ACADIA Pharmaceuticals Inc.·Phase 3· NCT06173531· Registry history of NCT06173531 on ClinicalTrials.gov (opens the registry)

   Updated Oct 15, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.